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Humanmicrobiome research is an actively developing area of inquiry, with ramifications for our life-
styles, our interactions with microbes, and how we treat disease. Advances depend on carefully
executed, controlled, and reproducible studies. Here, we provide a Primer for researchers from
diverse disciplines interested in conductingmicrobiome research.We discuss factors to be consid-
ered in the design, execution, and data analysis of microbiome studies. These recommendations
should help researchers to enter and contribute to this rapidly developing field.Introduction
Many studies have documented differences in the composition
of host-associated microbial communities between healthy
and disease states (Clemente et al., 2012; Karlsson et al.,
2013; Knights et al., 2013). For a growing number of diseases,
an altered microbiome is not just a marker of disease, but also
actively contributes to pathology (Chassaing et al., 2012). The
best empirical direct evidence that microbiomes can drive dis-
ease comes from experiments in which the microbiota from
diseased donors and controls are ‘‘transplanted’’ into healthy
germ-free hosts: if recipients of the disease-associated micro-
biome display the disease phenotype, themicrobiome is consid-
ered causal. This approach, pioneered by Jeffrey Gordon and his
group (Turnbaugh et al., 2006), has directly demonstrated that
the composition of gut microbial communities can alter host
metabolism (Koren et al., 2012; Vijay-Kumar et al., 2010), trans-
mit colitis (Garrett et al., 2007), and modulate type I diabetes
(Wen et al., 2008). The range of conditions with a host-micro-
biome interaction component continues to grow and has
recently started to include neurological conditions (Collins
et al., 2012). Consequently, researchers from a wide array of dis-
ciplines are interested in testing whether microbes, and espe-
cially gut microbes, are associated with various pathologies,
whether they actively participate in disease, and ultimately
whether they can present novel targets for therapies. This Primer
is intended for non-experts who are considering their first micro-
biome project and summarizes lessons learned from past suc-
cessful and unsuccessful projects.
Mammalian microbiome research has a long history (Savage,
1977), recently marked by dramatic increases in scale and scope
due to advances in DNA-sequencing technologies and in asso-
ciated computational methods. Anecdotal descriptions of com-
munity composition that set the standard in the recent past have250 Cell 158, July 17, 2014 ª2014 Elsevier Inc.given way to study designs that allow for repeated measure-
ments, error estimates, correlations of microbiota with covari-
ates, and increasingly sophisticated statistical tests (Knight
et al., 2012). Today, microbiome data are obtained predomi-
nantly in three forms: (1) 16S rRNA gene sequence surveys
that provide a view of microbiome membership, (2) metage-
nomic data used to portray functional potential, and (3) meta-
transcriptomic data to describe active gene expression. Here,
we focus primarily on 16S rRNA gene surveys because they
are economical and therefore scale to larger projects. 16S
rRNA gene sequence data provide a relatively unbiased charac-
terization of bacterial and archaeal diversity (Box 1 provides a
brief overview of methods for characterizing the diversity of
microbial eukaryotes and viruses). Regardless of the types of
microorganisms targeted or the methodology used to charac-
terize them, choices made at every step, from study design to
analysis, can impact results. This Primer highlights resources
that address specific technical questions and provides general
advice stemming from our collective experience working in the
field. Althoughwe focusmainly on themammalian gutmicrobiota,
many of the same issues apply to microbial communities of other
habitats. We have structured the Primer to answer questions that
are commonly raised by researchers entering the field (Figure 1).
Animal Studies
The Maternal Effect
A large fraction of microbiome studies are conducted in animals,
particularly rodents, as they offer attractive models for human
biology and their environmental conditions can be tightly
controlled. How animals are bred and raised is the most impor-
tant source of confounding factors in microbiome studies con-
ducted in animals. Inoculation of mice at birth (the maternal
effect) is a major factor shaping the composition of the
Box 1. Archaeal, Viral, and Eukaryotic Diversity
Most studies of the human microbiota describe bacterial diversity,
which typically dominates the cellular fraction of the microbiota; but
other taxa, including Archaea, fungi, and other microbial eukaryotes,
and viruses can be present.
Archaea. Archaeal diversity can be characterized using the
commonly employed 515F/806R primer set (and others), and their di-
versity can be analyzed in the same way as bacterial diversity. The
16S rRNA gene is the most widely used marker gene for the Archaea,
and their diversity is represented in reference data sets commonly
used for Bacteria.
Microbial Eukaryotes. Characterization of fungal communities, in
particular, is an active research area. In principle, the bioinformatics
pipeline is the same for eukaryoticmarker genes as for bacterial marker
genes (Iliev et al., 2012). However, the lack of a standard marker gene
and reference database means that the bioinformatics protocols are
not as standardized as for 16S rRNA gene analysis. For fungi, although
several marker gene options exist, the internal transcribed spacer (ITS)
region of the 16S rRNA gene is generally preferred for obtaining high
taxonomic resolution. The UNITE database (Abarenkov et al., 2010)
is often used for ITS sequence-based analyses of fungal sequences.
However, the ITS region is not amenable to alignments across distinct
fungal taxa, so ITS-based fungal community studies frequently do not
make use of phylogenetic metrics for alpha- and beta-diversity com-
parisons. One strategy that is being explored is using the 18S rRNA
gene and ITS in conjunction to define fungal phylogenetic trees. More-
over, the 18S rRNA gene can, in principle, be used to analyze eukary-
otic communities in the samemanner that 16S rRNA genes are used. A
reference database containing many eukaryotic sequences, such as
SILVA (Quast et al., 2013), should be used for such analyses. One
should confirm that the region of the 18S gene amplified discriminates
between the taxa studied and should be aware that the 18S rRNA gene
is not sufficient to characterize the eukaryotic phylogeny: trees built
from 18S sequence alone will likely be of questionable utility.
Viruses. Characterizing the human virome requires a different
approach because, unlike for cellular life, no gene or genomic region
is homologous across all viruses. The current approach for studying
these communities is to isolate virus-like particles (VLPs) using size
fractionation and to sequence those using metagenomics (Caporaso
et al., 2011a; Handley et al., 2012; Hurwitz et al., 2013; Reyes et al.,
2010). Alternatively, viruses can be characterized using DNA microar-
rays (Jack et al., 2009; Palacios et al., 2007).
Figure 1. Conducting a Microbiome Study
The sequential steps of conducting a microbiome study are diagramed, mir-
roring the sections of this Primer.microbiota and leads to a sharing of suites of bacteria between
littermates and their mothers that differentiates them frommem-
bers of other families and can persist over several generations
(Ley et al., 2005). The maternal effect determines the specific
suite of microbes available to colonize a host. Subsequently,
the individual host and host diet shapes the relative abundances
of these taxa (Ley et al., 2005; Rawls et al., 2006).
Mitigating the Maternal Effect
Thematernal effect is particularly problematic when it confounds
the experimental effect (see Figure 2 for an example). Because
littermates and even co-caged unrelated animals can share mi-
crobiotas due to coprophagy and other modes of transmission,
randomization of treatments across litters/cages becomes an
important aspect of experimental design. When the goal is to
compare the effect of different genotypes on the microbiome,
the options range from the use of germ-free mice gavaged
with the same inoculum to the use of mixed-genotype litters.When these options are not available, alternate approaches
include embryo transfers so that mixed genotypes are born
together, cross-fostering, and cohousing post weaning. The
last two options may be the least effective, as microbiotas will
be at least partly assembled. In large studies with multiple
litter/cage replicates, the variance in the data that is attributable
to the maternal effect can be accounted for in statistical models
(Benson et al., 2010).
Using the Maternal Effect to Maximize a Phenotype
In some cases, animals of different genotypes are maintained
separately in order to maximize the maternal effect and obtain
a strong microbial phenotype (Vaishnava et al., 2011; Vijay-Ku-
mar et al., 2010). Separately maintained mice can then be
cohoused to demonstrate the spread of a microbiota between
adults (Lawley et al., 2012; Ridaura et al., 2013). Conversely,
mice can be housed individually to minimize cross-contamina-
tion and maintain individual microbiotas (Ley et al., 2005).
Environment Matters: Microbiotas Vary Greatly among
Facilities
Mouse microbiotas can differ significantly between facilities
even if they have identical genotypes (Friswell et al., 2010). Envi-
ronmental conditions can differ between facilities—for instance,
the water acidity, food, bedding, and so on can differ. But it ap-
pears that different colonies harbor their own populations of
microbes as well. One striking example of this facility effect is
that of the segmented filamentous bacteria (SFB), which have
been reported more common in mice obtained from one com-
mon vendor (JAX) than another (Taconic) (Ivanov et al., 2009).Cell 158, July 17, 2014 ª2014 Elsevier Inc. 251
Figure 2. TheMaternal Effect CanConfound the Experimental Effect
(A and B) In this mock example, each point represents a gut microbial com-
munity as characterized by a set of 16S rRNA gene sequences from a single
mouse sample. In principal coordinates analysis (PCoA), points that are closer
together represent microbial communities that are more similar in sequence
composition. Samples from two different mouse genotypes are represented,
and the mice are derived from two different dams. In all panels, squares
indicate wild-type, and circles indicate mutant mouse genotypes. In (A), the
effect of genotype is confounded by the effect of a shared dam, whereas in (B),
the effect of dam is randomized across the two genotypes.Because their impact on the murine immune system is substan-
tial, their presence or absencemay confound experimental treat-
ments, particularly in immunological studies. Less is known
about the effects of housing regimen (e.g., specific pathogen
free [SPF] versus conventional corridors—and note that defini-
tions of SPF differ between facilities). For instance, the micro-
biota can differ enough between the SPF and conventional areas
within facilities to impact the prevalence of certain microbially
mediated phenotypes, such as type 1 diabetes in NOD mice
(Wen et al., 2008).
Human Studies
Commonly Applied Exclusion Criteria
In human studies, antibiotics, diet, body mass index, age, preg-
nancy, and ethnicity all have been reported in the literature to
have varying degrees of influence on themicrobiota composition
of the gut and of other body sites (Costello et al., 2012). Some of
these factors, notably antibiotic use, have effects strong enough
that they are often exclusion criteria (Cho et al., 2012; Dethlefsen
et al., 2008; Dethlefsen and Relman, 2011; Ubeda et al., 2010).
The exclusion criteria list from the NIH Human Microbiome Proj-
ect (HMP, see dbGAP) includes use of systemic antibiotics,
antifungals, antivirals, or antiparasitics within 6 months of sam-
pling. Each antibiotic can affect the microbiome differently,
and microbiome responses to a single antibiotic can also vary
substantially between individuals (Dethlefsen et al., 2008; Deth-
lefsen and Relman, 2011; Maurice et al., 2013). The 6month win-
dow of exclusion is somewhat arbitrary, however, and in some
cases, a shorter window has been applied based on results (Ko-
ren et al., 2012).
Controls
As in any well-controlled study, factors impacting the microbiota
should be balanced across the experimental groups. Selection
of subjects can be limited by the demographics of the population
available for study. Of course, a carefully selected control group,
such as case-matched controls, is preferable to the use of252 Cell 158, July 17, 2014 ª2014 Elsevier Inc.‘‘normal’’ individuals from another study. In time-series studies,
individuals can be treated as their own control by collecting
baseline samples before and during treatment (Dethlefsen
et al., 2008; Ley et al., 2006). In studies that do not include a
time series, the best-matched controls are monozygotic twins,
in which genotype is constant within twin pairs: for instance,
the effect of obesity on the microbiome has been studied in
monozygotic co-twins discordant for this phenotype (Smith
et al., 2013). Comparisons between monozygotic and dizygotic
twin pairs are used to differentiate between environmental and
genetic contributions to the microbiome, with the assumption
that early environmental influences are similar for both twin
types.
The Human Microbiome Project (HMP) generated the largest
human metagenomic study to date (Consortium, 2012a, b),
with the aim of providing a healthy reference set to be used for
comparison in future studies. This reference set, however, intro-
duces questions on how to best use the HMP data in new
studies. Combining new data sets with the HMP ismost effective
when the protocols are compatible and the effect size (i.e., differ-
ences between controls and subjects) of the study is large. For
example, in the Koren et al. (2012) study, the average be-
tween-subject microbial diversity was higher in the third
trimester of pregnancy compared to the first trimester, but
from the study’s data alone it was not possible to tell which
was most similar to a non-pregnant state. Comparison with the
HMP data set suggested that the first-trimester pattern was
typical of a non-pregnant state and that the third trimester was
aberrant (Koren et al., 2012). Another observation that emerged
from this comparison was a difference in overall diversity be-
tween the American (HMP) and Finnish (pregnancy study) sam-
ples. Because the data were generated separately, the source
of this difference could be technical artifacts or something
more interesting such as culture, diet, or geography. Indeed,
for studies with subtle effects on the microbiome such as those
associated with obesity or colon cancer, technical effects such
as PCR primer choice and DNA extraction method (see below)
can greatly outweigh the biological effects. Therefore, most
studies will require a carefully matched control group and cannot
rely on the HMP data set as a ‘‘universal’’ control group, just as
epidemiological studies cannot rely on a single ‘‘universal’’ refer-
ence population.
Before Sampling: Study Design Elements
Pilot Studies
The number of samples required for a microbiome study de-
pends on the effect size. A tool called ‘‘Evident’’ has been devel-
oped to aid in estimating the study size required based on the
anticipated effect size and similar previous studies (https://
github.com/biocore/Evident). However, because there is no
standardized way of reporting effect sizes and similar studies
may not exist, a pilot study may be necessary to define the effect
size.
Document Everything and Be Consistent
Before, during, and after sample collection, all information about
the sample and experimental procedures should be recorded.
This information will constitute the ‘‘metadata’’ (covariates) sur-
rounding the sample and will later be used in analyzing the
data. Furthermore, such analyses will be simplified when proce-
dures are as consistent as possible across groups and extra-
neous variables are minimized.
Repeated Sampling of Individuals
One question that comes up in study design is whether to resam-
ple individuals over time or whether to use those resources to
sample more individuals only once. An argument can be made
for both approaches depending on the goal of the study. For
instance, specific strains of gut bacteria have been demon-
strated to exist for many years within their hosts (Faith et al.,
2013). Many studies report that the adult human fecal microbiota
are ‘‘stable’’ over time, based on measures of within-subject
(alpha) versus between-subject (beta) diversity (see below for
further discussion) (HMPC, 2012a; Costello et al., 2009; Ley
et al., 2006; Turnbaugh et al., 2009; Wu et al., 2011). Further-
more, overall patterns of diversity across the human body have
been reproducible at different time points (Consortium, 2012b;
Costello et al., 2009). Thus, the stability of the adult gut micro-
biome can be used to argue that single time points are sufficient
to describe an individual’s microbiome. However, within-subject
diversity in one individual over time can approach the between-
subject diversity of many individuals at one time (Caporaso et al.,
2011b). Therefore, repeated sampling over time will provide a
more comprehensive view of the diversity.
Besides gaining amore comprehensive view of diversity for an
individual, time series have added benefits. Aspects of the mi-
crobiota that can be examined more effectively with time-series
data include changes in the presence/absence, in the member-
ship in the microbial community, and in the relative abundances
ofmicrobes. Time-series data can also reveal interesting charac-
teristics of themicrobiome that are not apparent from single time
points, such as the volatility of the microbiota (degree of change
between time points) and its resilience (bounce back after distur-
bance), both of which may be altered in disease or preclinical
states (Carvalho et al., 2012; Costello et al., 2012; Dethlefsen
et al., 2008; Lozupone et al., 2012). Recently developed analyt-
ical approaches (discussed below) can test whether an early
configuration of the microbiota predicts later configurations,
including predictions of the development of pathological states
such as colitis (Carvalho et al., 2012).
Obtaining and Storing Samples
Storage and transit conditions can be important variables in
microbiome study outcomes because they impact the DNA
yields and qualities. Therefore, whatever the conditions used, it
is most important to be consistent across samples and to keep
conditions constant (e.g., avoid inconsistent freeze thaws). The
most widely accepted protocols include immediate freezing
either on dry ice or in liquid nitrogen, followed by storage at
80C (Consortium, 2012a). However, this approach is not
always practical, particularly for stool samples, which may be
collected at home and then stored for an indeterminate time in
home freezers. Whether samples must be immediately frozen
(and at what temperature) or whether they can withstand a
period at room temperature remains controversial. However,
several studies have assessed the effects of storage conditions
on the composition of the microbiota by 16S rRNA gene
sequencing, and their results can help to guide a storage planbased on which aspects of the microbiota are impacted (for
instance, for fecal samples see Carroll et al., 2012, Lauber
et al., 2010, and Wu et al., 2010; for vaginal samples, see Bai
et al., 2012). Generally, these studies report that the effects of
short-term storage conditions on diversity and structure of the
communities are surprisingly small. Lauber and colleagues
recently showed that storage for 2 weeks at temperatures
ranging from 80C to 20C did not significantly affect patterns
of between-sample diversity or the abundance of major taxa
(Lauber et al., 2010). Note, however, that the number of freeze-
thaw cycles has been reported to have an effect on the compo-
sition of the microbial community (Sergeant et al., 2012) and
should be minimized. Studies incorporating metabolomics or
metatranscriptomics likely have more stringent requirements,
and the use of RNA stabilizers is still being evaluated. If samples
do experience big environmental fluctuations, it is important to
record these events so that the effect on the data can be as-
sessed using statistical modeling.
Long-term storage at 80C is currently the norm, but as
studies grow in size and number, repeated acquisition of ultra-
low freezers is becoming a burden. Another long-term storage
approach involves the lyophilization of samples and storage at
room temperature (Koren et al., 2012). Again, although storage
conditions may not affect the outcome of DNA-based studies
(16S rRNA PCR amplicon and metagenomic sequencing),
RNA-based studies may require different handling.
DNA Protocols
DNA Extraction and Amplification
Different DNA extraction protocols can result in different diversity
profiles because some cell types resist common mechanical or
chemical lysis methods (Salonen et al., 2010; Smith et al.,
2011). However, most studies (for example, the HMP) use widely
employed protocols and/or commercially available kits specific
to the sample type (e.g., blood versus stool). Extraction protocols
should be employed consistentlywithin a study, and thewide use
of commercial kits increases the possibility for consistency be-
tween independent studies. For samples from which very little
DNA can be extracted, DNA amplification may be necessary.
The whole-genome amplification methods MDA (multiple
displacement amplification; Dean et al., 2002) and MALBAC
(multiple annealing and looping-based amplification cycles;
Zong et al., 2012) are generally preferred, as they are best able
to maintain the diversity of DNAmolecules present in the original
sample. Moreover, both of these methods are suitable for ampli-
fication from single cells (Lasken, 2007; Zong et al., 2012).
Introduced Contaminants
Contamination issues are particularly important for samples with
lowmicrobial DNA concentrations. This concern was noted early
in microbial ecology studies: extreme environments with low
biomass were thought to contain similar microbes until the real-
ization was made that they were common lab contaminants
(Tanner et al., 1998). Testing commercial kits for contamination
is particularly important for studies using 16S rRNA gene ampli-
fication, which is highly sensitive to low levels of bacterial DNA
contamination. Testing involves running a blank extraction con-
trol through DNA extraction and PCR prior to working with sam-
ples. We have found that all commercial reagents, fromCell 158, July 17, 2014 ª2014 Elsevier Inc. 253
extraction kits to primers and polymerases, may be contami-
nated with microbial DNA, and levels can differ between batches
from the same vendor. Within a lab, PCR amplicons can become
contaminants, and many labs spatially separate pre- and post-
PCR steps.
If the negative extraction controls result in PCR products,
albeit less product than the samples, it may seem tempting to
‘‘sequence the negative control’’ and subtract those sequences
computationally. This process may seem like the sole recourse if
the extraction blank yields PCR product and the sample has
been used up. We encountered this issue in a study of the micro-
bial diversity of atheromas obtained from patients. One surprise
was that the extraction control replicates had very different
diversity profiles (O.K., R.K., and R.E.L., unpublished data).
Removal of sequences matching those in the negative controls
had a major impact on the study results and interpretation
(O.K., R.K., and R.E.L., unpublished data), undermining our con-
fidence in the data. We started the study over completely with
new clinical samples and clean blanks (Koren et al., 2011).
PCR
Selection of 16S Primers
In studies using 16S rRNA gene sequencing, the choice of primer
set depends on a number of factors, including compatibility with
previous studies and the specificities of the primers. For
instance, the bacterial 27F/338R primer set is biased against
the amplification of bifidobacterial 16S rRNA genes; the 515F/
806R primer set amplifies sequences from both Bacteria and
Archaea (Kuczynski et al., 2012). Because the phylogenetic infor-
mation varies along the length of the 16S rRNA gene (i.e., highly
conserved areas are the least informative), the choice of region is
more important than the length of the amplicon (Soergel et al.,
2012). The Earth Microbiome Project has PCR protocol informa-
tion for use on Illumina instruments and lists barcoded primer se-
quences (http://www.earthmicrobiome.org). In some cases,
sequence lengths obtained frompaired-end reads (particularly Il-
luminaMiSeq) may be long enough for overlap and can be joined
into a single longer sequence (a ‘‘contig’’). If there is little or no
overlap between sequence reads, both can be used in the down-
stream analyses, with at best modest performance enhance-
ments over using just one of the two sets (Soergel et al., 2012;
Werner et al., 2012b). In other words, if 16S rRNA gene diversity
data consist of paired-end Illumina data that cannot be joined, for
many applications it is acceptable to use one of the reads (often
the first read is of higher quality than the second).
Vetted Barcoded Primers Sets Are Available
Barcoded primers have been designed and optimized for multi-
plexing samples on the Roche 454 (http://www.hmpdacc.org/
tools_protocols/tools_protocols.php) and on Illumina platforms
(http://www.earthmicrobiome.org/emp-standard-protocols/
16s/). Error-correcting barcodes have the added advantage of
reducing the possibility that a sequence will be assigned to the
wrong sample (Hamady et al., 2008). We have found through
repeated use of barcode sets that the specific barcode
sequence used does not influence amplicon yield or diversity.
Effect of PCR Conditions on Results
Low DNA template concentration and high PCR cycle number
are known to introduce PCR bias. Tominimize bias, it is common254 Cell 158, July 17, 2014 ª2014 Elsevier Inc.practice to perform and pool multiple (i.e., triplicate) PCRs for
each sample, to minimize PCR cycle number, and to use a stan-
dard but relatively high DNA template concentration across sam-
ples (Acinas et al., 2005; Aird et al., 2011; Sipos et al., 2007). Use
of error-correcting polymerases may reduce PCR error, and
longer annealing times can also assist in reducing chimera for-
mation (Haas et al., 2011) (see below). Use of PCR enhancers
such as betaine or BSA can improve yields, and pre-incubations
with RNases can facilitate otherwise difficult reactions. In sys-
tems with large amounts of host contamination, such as plant
endophytic microbiomes, approaches such as PCR clamps
can help to reduce unwanted plant plastid contamination (Lund-
berg et al., 2013). The effects of these protocol variations on the
inferred microbial community composition have not been sys-
tematically evaluated. Best practice is, of course, to choose a
protocol and apply it consistently across all samples in a study
and even between studies to facilitate later comparisons.
Software for Detecting Sequence Chimeras
PCR errors are also common and are difficult to detect. Chi-
meras, which are caused by incomplete template extension
and give the appearance of recombination among disparate se-
quences (Haas et al., 2011), can cause inflated diversity. There
are several software options for chimera filtering, including Chi-
meraSlayer (Haas et al., 2011), UCHIME (Edgar et al., 2011),
DECIPHER (Wright et al., 2012), and Perseus (Quince et al.,
2011). These different methods often disagree with one another.
Noise introduced by PCR and sequencing errors has the great-
est impact on alpha diversity but generally has very little effect
on beta diversity (Ley et al., 2008).
16S rRNA Gene Sequence Data Analysis
Bacterial and archaeal 16S rRNA gene sequence data from com-
plex microbial communities present bioinformatical, statistical,
and computational challenges. Box 2 provides a list of software
options and computational requirements for 16S rRNA gene-
sequencing data. The most widely used software packages are
QIIME (Caporaso et al., 2010b) (http://www.qiime.org) and
mothur (Schloss et al., 2009) (http://www.mothur.org). Both
packages are open source and have online tutorials and forums.
We focus our discussion on the QIIME package (as several of the
authors of this Primer are developers of QIIME), but many of the
themes discussed here are common to both software packages.
Data Filtering and Normalization
Quality Filtering. Marker gene (i.e., 16S rRNA gene) analysis
generally begins with demultiplexing of sequence reads,
whereby each sequence is assigned to its sample of origin based
on the barcode. For computational efficiency, quality filtering is
also typically applied at this stage. Reads not matching any bar-
code are discarded, as are sequences that fail to meet minimum
quality thresholds. These quality thresholds are sequencing-
platform specific and may be based on features, including qual-
ity scores provided by the sequencing instrument, read length,
and the presence of ambiguous base calls. Denoising was devel-
oped for reducing sequencing errors on the 454 platform and
does not apply to Illumina data (Reeder and Knight, 2010). We
recently investigated Illumina quality-filtering parameters in
detail, and the recommendations from this study (Bokulich
et al., 2013a) have been implemented inQIIME. Additional quality
Box 2. Software for Analysis of 16S rRNA Amplicon Data
Several software packages are available for the analysis of sequenced
amplicons. The most commonly used are QIIME (Caporaso et al.,
2010b), RDP (Cole et al., 2009), mothur (Schloss et al., 2009), and
VAMPS (http://vamps.mbl.edu/). RDP and VAMPS are both web-
based tools, whereas QIIME and mothur are primarily accessed
through command-line interfaces. Galaxy (Blankenberg et al., 2010;
Giardine et al., 2005; Goecks et al., 2010) and CloVR (Angiuoli et al.,
2011) wrappers have been developed to enable access to these tools
via the web, and QIIME is also web accessible through the IPython
Notebook (Caporaso et al., 2012). We focus our discussion of compu-
tational resources on QIIME because several of the authors of this
Primer have development and leadership roles in the QIIME project.
QIIME is implemented as a collection of command-line scripts de-
signed to take users from raw sequence data and sample metadata
through publication-quality graphics and statistics. Some of these
scripts are primarily wrappers of one or more other software packages,
such as uclust (Edgar, 2010), RDP classifier (Cole et al., 2009), muscle
(Edgar, 2004), and PyNAST (Caporaso et al., 2010a). Other QIIME
scripts directly implement statistical tests, diversity estimators, and
data visualization tools. QIIME can be run on systems ranging from
personal computers to computing clusters and clouds. Native installa-
tion is supported on Linux andMacOS X; installation via Oracle Virtual-
Box is supported on Linux, Mac OS X, and Windows; and installation
via MacQIIME is supported on Mac OS X. Additionally, we officially
support use of QIIME on the commercial Amazon Web Services
(AWS) Elastic Compute Cloud (EC2) and developers of academic
computing clouds including iPlant (Goff et al., 2011) and Magellan
(https://www.nersc.gov/research-and-development/
cloud-computing/). AWS is an excellent resource for users without
their own computing hardware, and tools like StarCluster (http://star.
mit.edu/cluster/) facilitate the usage of cluster computing environ-
ments in the cloud.filtering can occur downstream in data analysis; for instance, se-
quences observed only one time or only in a single sample may
be considered artifacts and are often discarded. It is rare, though
not impossible, for the same errors to be independently gener-
ated in different samples (Lahr and Katz, 2009).
Uneven Sequence Counts across Samples. The number of se-
quences obtained in a sequencing run can vary across samples
for technical rather than biological reasons, and these
sequencing depth artifacts can affect diversity estimates. One
approach to account for variable sequencing depth is to use fre-
quencies of OTUs (operational taxonomic units, described
below) within samples (i.e., to normalize by total sample
sequence count). We recommend against this approach, as
we have found that it is subject to statistical pitfalls and can
lead to samples clustering by sequencing depth (Friedman and
Alm, 2012; C. Lozupone, J.G.C., and R.K., unpublished data).
In a second approach termed rarefaction, equal numbers of se-
quences are randomly selected from each sample. The number
of sequences drawn is usually the sequence count of the sample
with the smallest acceptable number of sequences. This
sequence count number should reflect a balance between re-
taining as many sequences as possible without excluding too
many low-sequence samples. A major disadvantage of rarefac-
tion is that valuable data from high-sequence count samples are
discarded. Thus, rarefaction can lead to a more conservativeview of the abundances of rarer taxa across samples. Addition-
ally, rarefaction has recently been shown to introduce errors in
analyses, and alternatives to rarefaction have been proposed
(McMurdie and Holmes, 2013). Rarefaction is not necessary
when OTU abundances are modeled as response variables in
statistical models: total sequence counts can be retained and
used as a factor in multivariate models (see below).
Identifying the Microbial Groups: OTU Analysis
Approaches to ‘‘Picking OTUs.’’ After quality filtering, sequences
are clustered into operational taxonomic units (OTUs; some-
times referred to as phylotypes), which provide a working
name for groups of related bacteria. OTUs are based on
sequence identity (%ID), and various thresholds of sequence
identity are used to represent different taxonomic levels (e.g.,
97% ID for species, 95% for genera). These taxonomic thresh-
olds are known to be very rough estimates: the degree of
sequence variability depends on the region of the 16S rRNA
gene sequenced, the length of the amplicon, and the specific
taxa in question. A sequence identity of 97% is most often
used to denote bacterial ‘‘species’’ despite the fact that there
is no rigorous species concept for bacteria. Nonetheless, these
OTU naming conventions are useful because they have become
the shared vocabulary used to discuss sequence-based obser-
vations.
Types of OTU-Picking Algorithms. The specific OTU-picking
algorithm used can have amajor impact on downstream findings
and interpretations of the data. OTU clustering algorithms fall
into three categories: de novo, closed reference, and open refer-
ence. In de novo OTU picking, sequences are clustered into
OTUs, without any external reference sequences (Schloss and
Handelsman, 2005). In contrast, closed-OTU picking uses a
reference sequence database, and sample sequences that fail
to match the reference sequence database are discarded.
Open-reference OTU picking is a two-step process consisting
of first closed-reference OTU picking followed by de novo clus-
tering of sequences that fail to match to the reference database.
The pros and cons of these three methods are detailed here
(http://qiime.org/tutorials/otu_picking.html). We recommend
open-reference OTU picking because it retains all sequence
data, though there are circumstances for which this method is
not applicable. For example, when combining sequence data
from different regions of the 16S rRNA gene, a closed-reference
OTU-picking approach must be used because sequences from
different regions of the same 16S rRNA gene would otherwise
cluster into different de novo OTUs.
In reference-based OTU picking, sequences are clustered
against a reference database such as Greengenes (McDonald
et al., 2012), Ribosomal Database Project (RDP) (Cole et al.,
2009), or SILVA (Quast et al., 2013). Note that these databases
are periodically updated, and the taxonomic information can
change between versions. The human gut microbiota are well
represented in the databases compared to other sample types.
We have found that 5% of the human gut sequences and up
to 50% of soil microbial community sequences might be dis-
carded in closed-reference OTU picking due to failure to match
to a database sequence (Werner et al., 2012a). Additionally, the
mouse gut microbiota are less well represented in databases
compared to human gut microbiota. As more sequences areCell 158, July 17, 2014 ª2014 Elsevier Inc. 255
Box 3. Comparing Species Composition between Samples
Beta diversity metrics provide a measure of the degree to which sam-
ples differ from one another and can reveal aspects of microbial ecol-
ogy that are not apparent from looking at the composition of individual
samples. Generally, beta diversity metrics are remarkably robust to is-
sues such as low sequence counts and noise. Beta diversity metrics
can be grouped in a couple of different ways. First, they can be quan-
titative (using sequence abundance, e.g., Bray-Curtis or weighted
UniFrac) or qualitative (considering only presence-absence of se-
quences, e.g., binary Jaccard or unweighted UniFrac). Second, they
can be phylogeny based (the UniFrac metrics) or not (Bray-Curtis, etc.).
The figure shows an explanation of why phylogeny-based metrics such
as UniFrac can outperform other metrics in community comparisons.
The top three boxes represent communities, eachwith three taxa, shown
as OTUs and as pictures of animals. When the phylogenetic relationship
of theOTUs isnot known (seestarphylogeny in lower-left), the threecom-
munities appear equally unrelated (lower-left PCoA plot). When their py-
logeny is taken intoaccount (i.e.,mammalsaremore related toeachother
thanbirds in thephylogenyon the right), then theorange (bird) community
is shown to be more distant in the in PCoA plot (lower-right).added to the databases, matching efficiencies are improving
across sample types.
Binning Sequences by Taxonomy versus %ID. OTU-picking
algorithms followed by taxonomic assignment of representative
OTU sequences yield lists of OTUs with taxonomic labels. Many
OTUs will lack a complete taxonomy label; for example, the clas-
sification might include a family level categorization but might
lack genus or species categorization. Incomplete taxonomy
can result from either a lack of confidence in where the OTU
fits in the phylogeny (i.e., several matches are equally likely
and there is no consensus) or from matching to a branch in the
phylogeny that lacks taxonomic information. There is a tempta-
tion to emphasize results for taxa that have associated genus/
species names. However, OTUs without genus/species informa-
tion are frequently both more abundant and more representative
of total diversity than are OTUs with genus/species names
(Werner et al., 2012a). OTUs with genus/species information
are more likely to include a reference strain that is cultured,
and these organisms are not randomly distributed across the
phylogeny. Some types of Bacteria, such as Proteobacteria,
lend themselves willingly to culturing, whereas the majority of
phyla do not.
There are two approaches to assessing the abundances of
higher-level taxonomic groups, such as orders or families: sum-
ming the sequences for all OTUs belonging to the group of inter-
est (collapsing taxonomies) or picking OTUs at a lower %ID. As
%ID thresholds do not necessarily map onto the taxonomy well,
these can, in principle, yield different results. A word of caution
about the genus level: members of the same bacterial genus
are not necessarily each other’s closest relatives. For example,
the genus Clostridium is found in different bacterial families.
Thus, summing sequence counts for OTUs assigned to the
genus ‘‘Clostridium’’ will have the effect of combining sequences
for potentially very distantly related organisms and will yield a
meaningless category. Clostridium species are in the process
of being reclassified into new genera (e.g.,Blautia). However, un-
til the tree is fully curated, the phylogenetics of organisms as-
signed common genus names (another example is Eubacterium)
should be carefully checked before combining sequence sets. In
addition, all OTUs that have no genus designation will be
collapsed into a ‘‘no-name’’ genus, which could be an arbitrary
mix of OTUs from across their family. Because of these issues,
diversity calculations should be performed before collapsing
data by taxonomy. We strongly recommend against collapsing
OTUs at the genus level unless the study addresses specific
known monophyletic genera, i.e., genera in which all species
are each other’s close relatives.
Microbiota Diversity Analysis
Microbiome diversity is typically described in terms of within (i.e.,
alpha) and between samples (i.e., beta) diversities. Methods for
analyzing alpha and beta diversity (see Box 3) have been dis-
cussed at length in various reviews (Kuczynski et al., 2010; Loz-
upone andKnight, 2008). Here,we focus instead on the visualiza-
tion, clustering, and modeling of the diversity in microbiota data.
Data Visualization: Principal Coordinates Analysis
Ordination techniques, such as principal coordinates analysis
(PCoA), reduce the dimensionality of microbiome data sets so256 Cell 158, July 17, 2014 ª2014 Elsevier Inc.that a summary of the beta diversity relationships can be visual-
ized in two- or three-dimensional scatterplots. The principal co-
ordinates (PCs), each of which explains a certain fraction of the
variability (formally called inertia), observed in the data set are
plotted to create a visual representation of themicrobial commu-
nity compositional differences among samples (Figure 3). Obser-
vations based on PCoA plots can be substantiated with statisti-
cal analyses that assess the clusters (see Figure 3 legend).
PCs Explaining a Low Percentage of Variation Can Yield
Biological Insights
When the individual PCs explain small fractions of the total vari-
ation, it may nevertheless be possible to infer the factors driving
the separation of samples along the PC. For example, Figure 4
illustrates an example of PC1 relating to the OTU abundances
across samples (see Koren et al., 2012 for a real example). In
many cases, despite having a low percentage of the variance ex-
plained, biological patterns are still revealed (Kuczynski et al.,
2010).
Figure 3. Principal Coordinates Analysis andClassificationMethods
(A) Principal coordinates (PCs) from a principal coordinates analysis (PCoA)
are plotted against each other to summarize the microbial community
compositional differences between samples. Each point represents a single
sample, and the distance between points represents how compositionally
different the samples are from one another. The points are colored by health
state, showing a clear difference in the microbial community composition
between diseased (green) and healthy (purple).
(B) Classification methods can be used to determine which OTUs discriminate
between the healthy and diseased groups, and a heatmap can be used to
visualize over/under representation of these OTUs in the groups. In this
example, the abundances of the four discriminatory OTUs (rows) are colored
from low abundance (blue) to high abundance (red) in the 47 samples (col-
umns). Both the PCoA plot and the sample dendrogram in the heatmap show
that the separation between disease and health states is not perfect. There is
some overlap in the composition of these samples, though the placement of
points in the PCoA plot is far from random. This observation should be sup-
ported with statistical analysis. For example, a Monte Carlo two-sample t test,
comparing the distribution of within-group distances to the distribution of
between-group distances applied to these data tells us that this clustering
pattern is statistically significant.Classification and Clustering
Classification methods can be supervised or unsupervised de-
pending on whether categorical metadata (i.e., discrete sample
information like diet, genotype, diseased, etc.) is used. Super-
vised classification methods require knowledge of which sam-
ples belong to which group, whereas unsupervised methods
do not. Both methods are useful, and the choice of method de-
pends on the information available about the samples and the
question being asked.
Supervised classification methods can be used to determine
which taxa differ between predefined groups of samples (e.g.,
diseased versus healthy) and to build models that use these
discriminatory taxa to predict the classification of a new sample.
Examples of commonly employed supervised classification
methods are described in Knights et al. (2011).
Unsupervised classification (clustering), on the other hand,
does not make use of any prior knowledge about the samples.Samples are categorized into clusters based on the abundances
of specific taxa. A between-sample distance metric, such as
UniFrac or Bray-Curtis, is used to generate these clusters. Clus-
tering approaches can differ based on whether the number of
clusters is preset or optimized to produce maximally distinct
clusters. The specific methods used in clustering (both distance
metrics and clustering algorithms) can affect the outcome and
the interpretation of clustering analyses (Koren et al., 2013).
For this reason, it is important to perform clustering in several
different ways to ensure that the existence of clusters is not
dependent on just one set of parameters.
Koren et al. (2013) explored the sensitivities of some of these
methods using data sets from the HMP and MetaHIT. As an
example, we illustrate in Figure 4 how some of these approaches
assume that clusters exist even if the structure of the data set is a
gradient. These approaches will delineate distinct clusters
regardless of the fact that none actually exist. We have recom-
mended that several approaches to clustering be used in parallel
(Koren et al., 2013). If distinct clusters are identified as robust us-
ing several methods, the enrichment of predefined sample clas-
ses within the clusters can be explored, as well as the biological
basis of the clustering. If the samples do appear to form distinct
clusters, these can then be labeled as classes, and one can
search for OTUs that discriminate these classes.
Clustering of human gutmicrobiome samples led to the idea of
enterotypes, or distinct compositions of the gut microbial com-
munities in different individuals (Arumugam et al., 2011). As
data sets have expanded, these discrete categories have
emerged as the extremes of continuous gradients, with some
configurations being more prevalent than others in certain pop-
ulations (Koren et al., 2013). Within any given study, it may be
possible to group samples into discrete types based on the com-
munity composition, but care should be taken to determine
whether a discrete clustering pattern is present or whether
more data would reveal a gradient or other alternative structure
in the data.
Modeling
The data that can be extracted from a microbiome analysis take
many forms (e.g., alpha diversity measures, PCs of the beta
diversity PCoA, and the abundances of OTUs) that can be
used as response variables in statistical models. Abundances
of OTUs, in particular, are seldom normally distributed because
many samples will have zero counts for rare OTUs. Such zero-
inflated, sparse data sets trigger the need for either transforma-
tions or nonparametric statistics. Note that a single transforma-
tion approachmay not work equally well for all OTUs. In addition,
caremust be taken to avoidmultiple comparison issues, as there
are generally thousands of OTUs being tested for association
with a few states (e.g., healthy or diseased), so many spurious
associations are expected. Consultation with a statistician is
highly recommended at both the experimental design phase
and during the analysis phase.
Recent large-scale analyses provide examples of how to apply
multivariate statistics to 16S rRNA sequence data (Bokulich
et al., 2013b; Lundberg et al., 2012; McMurdie and Holmes,
2013; Peiffer et al., 2013). The study of Benson et al. (2010) pro-
vides an example of how variation induced by thematernal effect
can be controlled for statistically. In human studies, covariatesCell 158, July 17, 2014 ª2014 Elsevier Inc. 257
Figure 4. UseCautionwhenApplying UnsupervisedClassification to
Data Gradients
(A–C) In this simulated microbiome data set, a principal coordinates analysis
(PCoA) was performed, and the first two principal coordinates, PC1 and PC2,
are plotted. The exact same set of points is shown in panels (A–E) but is
colored differently. In (A), samples are all colored black to show that they form
gradients along PCs 1 and 2. In (B) and (C), two sets of clusters were desig-
nated by bisecting the spread of samples. In (B), half of the samples form the
red cluster, and the second half form the Blue cluster along PC1. In (C), half of
the samples are in the Green cluster, and the second half form the Yellow
cluster along PC2. In (B) and (C), starplots display inferred clusters; this display
can give the misleading impression of distinct clusters (see A; the data
structure consists of gradients, not distinct clusters).
(D–G) In (D) and (E), the samples are colored according to the abundances of
the taxa that drive their separation along PCs 1 and 2. (D) The abundance of
sequences belonging to the Bacteroidetes phylum drives the spread of sam-
ples along PC1; (E) abundances of Proteobacteria in the samples drive their
spread along PC2. When the relative abundances for these phyla in samples
are averaged (F and G), it is apparent that the Blue samples, which are at the
‘‘low end’’ of the Bacteroidetes gradient, have lower means than the Red
samples, which are at the high end (F). Similarly, because the Yellow/Green
samples are spread along PC2 according to their abundance of Proteobac-
teria, these two groups will also exhibit different mean abundances (G).
Therefore, plotting mean values of the abundances of taxa that drive the
gradients in the PCoA plots does not constitute a validation of the PCoA
patterns.
258 Cell 158, July 17, 2014 ª2014 Elsevier Inc.such as gender, age, and body mass index can be included in
models. Technical sources of variation in microbiome data are
also very important to control for statistically. These include,
for example, the specific run of a sequencing instrument in
studies that include multiple runs. We have found that the Roche
454 instrument in particular can introduce variation from run to
run, which can be controlled for statistically by including the
run information for each sample in the models (and by random-
izing samples across runs). Note that, within the same analysis,
we strongly recommend against incorporating data from
different instruments (e.g., Illumina and 454 platforms). Other
sources of variation include factors such as the date (or season)
at which samples were collected, the time maintained in
freezers, and the identity of the person handling the samples.
When OTU abundances are the response variable in the models,
sequence count per sample can be included as a covariate. This
alternative approach to rarefying sequence data increases
power by retaining the full data set.
Concluding a Study: Standardized Databases
As the microbiome field matures and technology further de-
velops, improvements and standardization of microbiome
research are expected. Each newmicrobiome study pushes for-
ward the guidelines and requirements to conduct and publish a
microbiome study. It is therefore imperative that investigators
stay abreast of the current practices in the microbiome field.
For all projects (16S rRNA amplicon, metagenomics, or meta-
transcriptomics), an important step is the submission of both
the sequence files and the metadata (covariates) associated
with each sample to public databases. Several database initia-
tives exist for this purpose, including QIIME, MG-RAST, and
NCBI’s and EBI’s respective short-read archives (SRA). In gen-
eral, journals and funding agencies require deposition of data
into INSDC (the International Nucleotide Sequence Database
Collaboration, which encompasses NCBI, EBI and DDBJ). Un-
structured archival resources such as Dryad allow public hosting
of large data sets but do not require standardization of format;
this makes data deposition easy but data reuse essentially
impossible. The QIIME database is not intended as an archival
repository of data but does provide a number of tools for rapidly
comparing data from different microbial communities. Given the
growing number of independent microbiome studies, there is
great interest in being able to combine data frommultiple studies
to increase power through meta-analysis (Koren et al., 2013). In
addition to standardizing protocols for sample processing and
sequencing, meta-analysis will only be possible if metadata
collection and reporting is also standardized. To achieve this
goal, the Genomic Standard Consortium developed the mini-
mum information about a marker gene sequence (MIMARKS)
(Yilmaz et al., 2011), part of the MIxS family of standards that al-
lows description of a wide range of omics data sets.Final Remarks
The analysis of microbial community diversity is rapidly
becoming a component of a vast array of different research pro-
grams, ranging from neurobiology to nutrition. We focused this
Primer on 16S rRNA gene diversity studies because it is an entry
point into the field. However, increasingly powerful algorithms
coupled with more accessible sequencing strategies make
whole microbial genome reconstructions from metagenomic
samples a growing reality and hint at the future of research in
the field. For example, metagenomic analysis was recently
used to observe characteristics of temporal succession of the
gut microbiome in preterm infants and proved capable of identi-
fying relevant strains and functions of putative bacterial patho-
gens (Morowitz et al., 2011). Similarly, applying these tools
allowed reconstruction of genomes from a new uncultivated
phylum, Melainabacteria, that is common in the human gut (Di
Rienzi et al., 2013).
Regardless of the methodologies employed to study the mi-
crobiome, many fundamentals remain the same. These recom-
mended practices distill down to the following: (1) carefully
design the study to reduce confounding factors, (2) apply consis-
tent experimental and analytic methods throughout, (3) keep
good records so that all possible metadata can be used in statis-
tical models, (4) match the software and the statistical toolkits to
the data sets generated and keep detailed records of the bioin-
formatics steps of the analysis (including versions of software
and lists of commands), and (5) deposit all data in public data-
bases using standard formats. This last recommendation incor-
porates each individual researcher and study into the larger
community and allows a second generation of analyses that
mine the databases for larger trends.ACKNOWLEDGMENTS
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